International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials.
The Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody-Vaccine Immune Monitoring Consortium (CAVD/CA-VIMC) assisted an international network of laboratories in transferring a validated assay used to judge HIV-1 vaccine immunogenicity in compliance with Good Clinical Laboratory Practice...
Main Authors: | , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Public Library of Science (PLoS)
2012-01-01
|
丛编: | PLoS ONE |
在线阅读: | http://europepmc.org/articles/PMC3267749?pdf=render |